Wr. Waters et al., Modulation of Mycobacterium bovis-specific responses of bovine peripheral blood mononuclear cells by 1,25-dihydroxyvitamin D-3, CL DIAG LAB, 8(6), 2001, pp. 1204-1212
Historically, administration of vitamin D has been considered beneficial in
the treatment of tuberculosis. The interaction of this vitamin {i.e., 1,25
-dihydroxyvitamin D-3 [1,25(OH)(2)D-3]} with the antitubercular immune resp
onse, however, is not clear. In the present study, in vitro recall response
s of peripheral blood mononuclear cells (PBMC) from cattle infected with My
cobacterium bovis were used to study the immune-modulatory effects of 1,25(
OH)(2)D-3 on M. bovis-specific responses in vitro. Addition of 1 or 10 nM 1
,25(OH)(2)D-3 inhibited M. bovis-specific proliferative responses of PBMC f
rom M. bovis-infected cattle, affecting predominately the CD4(+) cell subse
t. In addition, 1,25(OH)(2)D-3 inhibited M. bovis-specific gamma interferon
(IFN-gamma) production yet enhanced M. bovis-specific nitric oxide (NO) pr
oduction. Lymphocyte apoptosis, measured by flow cytometry using annexin-V
staining, was diminished by addition of 1,25(OH)2D3 to PBMC cultures. These
findings support the current hypothesis that 1,25(OH)(2)D-3 enhances mycob
acterial killing by increasing NO production, a potent antimicrobial mechan
ism of activated macrophages, and suggest that 1,25(OH)2D3 limits host dama
ge by decreasing M. bovis-induced IFN-gamma production.